PHASE-II TRIAL BIWEEKLY PACLITAXEL (P), DOXORUBICIN (D) AND GEMCITABINE (G) AS FIRST LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER (MBC) -PRELIMINARY-RESULTS
A. Lozano et al., PHASE-II TRIAL BIWEEKLY PACLITAXEL (P), DOXORUBICIN (D) AND GEMCITABINE (G) AS FIRST LINE CHEMOTHERAPY FOR METASTATIC BREAST-CANCER (MBC) -PRELIMINARY-RESULTS, Annals of oncology, 9, 1998, pp. 84-84